Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
49 /100
MEDIUM RISK
Score updated Aug 28, 2026

RNXT — RenovoRx, Inc. Dilution Risk Tracker

Track RNXT dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track RNXT — Get alerts when the score changes →

As of August 28, 2026, RenovoRx, Inc. (RNXT) has a DilutionWatch DilutionScore of 49/100, rated MEDIUM dilution risk. RenovoRx, Inc. has a market capitalization of $41.01M, 45.13M shares outstanding, 33 institutional holders tracked. Stored dilution-related fields include shelf registration capacity of $10.00M, ATM program capacity of $10.00M, 557.6K outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
65
💰 Cash Runway
65
📊 Float Risk
7
⚠️ Warrant Exposure
15
🔄 Convertible Debt
15

Dilution Forecast

⛈️
Warning
High probability of dilution event
model est. 48%
🔄 Reverse Split model est. 65%
• 50-day avg $0.94 below $1 exchange minimum
• 12 months cash with weak price
💰 Capital Raise model 53%
• Under 12 months cash (12mo)
• Active shelf registration ($10M, 24% of market cap)
🔔 Track RNXT — Get forecast alerts →

Market Data

Market Cap$41.01M
Shares Outstanding45.13M
Float39.90M
Cash$11.53M
Debt$78.0K
Short InterestN/A

Institutional Holdings

QoQ: ↑ 57.6% shares (2026Q1 vs prior)
33 institutional holders · 10.39M shares
#1 AIGH Capital Management LLC 3.71M shares
#2 VANGUARD CAPITAL MANAGEMENT LLC 2.89M shares
#3 Bleichroeder LP 1.67M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest283.4K
Days to Cover1.4
% of Float0.7%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2025-12-31
xbrl XBRL CONVERTIBLE 2021-12-31
EFFECT EFFECT 2026-04-27
424B3 ATM 2026-04-27
S-3 SHELF 2026-04-16
Full SEC filing analysis available with free account

Recent News

No recent news

Factual RNXT Dilution Snapshot

RenovoRx, Inc. (RNXT) has a DilutionScore of 49/100, rated Medium dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track RNXT Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking RNXT — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for RNXT
RNXT FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.